The artificial intelligence-enabled drug research and development startup XtalPi brought home nearly $319 million in its Series C funding round, announced Monday.
SoftBank Vision Fund 2, PICC Capital and Morningside co-led the investment round, while Tencent, Sequoia China, China Life and SIG also made contributions.
WHAT IT DOES
Founded in 2014 by a group of quantum physicists at MIT, XtalPi...
